AKT1 and cancer: Moreover, TRAF6 has been reported to enhance the ubiquitination and activation of protein kinase B (AKT) and transforming growth factor activated kinase 1 (TAK1), leading to cell cycle progression, proliferation, and migration of cancer cells along with impairment of apoptosis in cancer cells.